Sign inGet started

Bright Rex

Insider CIK 1327501 · SMDID Director · MNLO Director · FOMX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VYNE VYNE Therapeutics Inc. A Award deriv2021-07-192021-07-2020,500— $020,500SEC↗
MNLO Menlo Therapeutics Inc. A Award deriv2020-08-032020-08-0522,500— $022,500SEC↗
MNLO Menlo Therapeutics Inc. A Award deriv2020-03-192020-03-2345,000— $045,000SEC↗
FOMX Foamix Pharmaceuticals Ltd D To issuer deriv2020-03-092020-03-1138,156— $00SEC↗
FOMX Foamix Pharmaceuticals Ltd D To issuer deriv2020-03-092020-03-1127,000— $00SEC↗
FOMX Foamix Pharmaceuticals Ltd D To issuer deriv2020-03-092020-03-1121,562— $00SEC↗
FOMX Foamix Pharmaceuticals Ltd D To issuer deriv2020-03-092020-03-1124,947— $00SEC↗
FOMX Foamix Pharmaceuticals Ltd D To issuer deriv2020-03-092020-03-1149,412— $00SEC↗
MNLO Menlo Therapeutics Inc. A Award deriv2020-03-092020-03-1114,778— $014,778SEC↗
MNLO Menlo Therapeutics Inc. A Award deriv2020-03-092020-03-1129,271— $029,271SEC↗
MNLO Menlo Therapeutics Inc. A Award deriv2020-03-092020-03-1122,603— $022,603SEC↗
MNLO Menlo Therapeutics Inc. A Award deriv2020-03-092020-03-1112,773— $012,773SEC↗
MNLO Menlo Therapeutics Inc. A Award deriv2020-03-092020-03-1115,994— $015,994SEC↗
FOMX Foamix Pharmaceuticals Ltd A Award deriv2020-02-272020-03-0338,156— $038,156SEC↗
FOMX Foamix Pharmaceuticals Ltd A Award deriv2019-05-162019-05-2049,412— $049,412SEC↗
FOMX Foamix Pharmaceuticals Ltd A Award deriv2018-05-082018-05-1024,947— $024,947SEC↗
RESX RestorGenex Corp A Award deriv2014-07-242014-07-2961,085— $061,085SEC↗
SMDID RestorGenex Corp A Award deriv2014-02-052014-03-101,650,000— $01,650,000SEC↗